Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|May 4, 2016
Design and rationale of dabigatran's stroke prevention in real life in Turkey (D-SPIRIT)Uğur Önsel Türk, Emin Alioğlu, Eşref Tunçer, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|December 9, 2021
Dabigatran for stroke prevention in real life in a sample of population from Turkey: D-SPIRIT registryCihan Altın, Caner Topaloğlu, Nurullah Çetin, et al.
Clinical Cardiology|May 21, 2026
Rationale and Design of the Türkiye Heart Failure (TURK-HF) RegistryUmut Kocabas, Selda Murat, Tarık Kıvrak, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|July 26, 2021
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)Berkay Ekici, Mehmet Yaman, Murathan Küçük, et al.
ESC Heart Failure|September 28, 2024
Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART studyUmut Kocabas, Isil Ergin, Veysel Yavuz, et al.
Clinical Cardiology|January 28, 2025
Incidence and Predictors of Clinical Outcomes in Real-Life Patients With Atrial Fibrillation Treated With Oral Factor Xa Inhibitors: The Follow-Up Results of the ANATOLIA-AF StudyUmut Kocabaş, Isil Ergin, Sadi Can Sönmez, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|November 1, 2022
The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study)Cihan Altın, Kaan Okyay, Mehmet Kış, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|March 14, 2023
Real-World Evaluation of Anticoagulant Treatment Patterns in Patients with Atrial Fibrillation: Data from Multicenter ROTA StudyUmut Kocabaş, Işıl Ergin, Veysel Yavuz, et al.
Cardiovascular Drugs and Therapy|December 17, 2022
PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF StudyUmut Kocabaş, Isil Ergin, Veysel Yavuz, et al.
Pageof 3